Bone Targeted Therapies in Early Breast Cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Oncology
Link
http://link.springer.com/content/pdf/10.1007/s11864-011-0163-3.pdf
Reference43 articles.
1. Bloomfield DJ. Should bisphosphonates be part of the standard therapy of patients with multiple myeloma or bone metastases from other cancers? an evidence- based review. J Clin Oncol. 1998;16:1218–25.
2. Saad F, Gleason DM, Murray R, et al. A randomised placebo- controlled trial of zoledronic acid in patients with metastatic prostate carcinoma. J Natl Canc Inst. 2002;94:1458–68.
3. Rosen LS, Gordon D, Tchekmedyian S, et al. Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, double-blind, randomized trial. The Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group. J Clin Oncol. 2003;21:3150–7.
4. Van Poznak C, Sauter NP, et al. Clinical management of osteoporosis in women with a history of breast carcinoma. Cancer. 2005;104(3):443.
5. Lacey DL, Timms E, Tan HL, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 1998;93:165–76.
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Adherence to bone health guidelines in patients with hormone receptor-positive early breast cancer: Status and clinical impact in a Swiss cohort experience;Bone Reports;2022-06
2. Clinicopathological features and prognostic evaluation of bone metastasis in triple-negative breast cancer;Journal of Cancer Research and Therapeutics;2017
3. Systemic Therapies to Reduce the Risk of Recurrence in Early Breast Cancer: New Strategies;Breast Cancer Survivorship;2016
4. Singapore Cancer Network (SCAN) Guidelines for Bisphosphonate Use in the Adjuvant Breast Cancer Setting;Annals of the Academy of Medicine, Singapore;2015-10-15
5. Bisphosphonates in breast cancer;International Journal of Cancer;2014-05-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3